Firefly Neuroscience identifies novel EEG biomarker for PTSD using FDA-cleared Evoke System

Firefly Neuroscience, Inc.

Firefly Neuroscience, Inc.

AIFF

0.00
  • Firefly Neuroscience disclosed discovery of a novel electrophysiological biomarker for PTSD using brain scans from its FDA-510(k)-cleared Evoke System.
  • The announcement did not cite prior conference disclosure; no future presentation timing was provided.
  • Company described a reproducible neural pattern that distinguishes PTSD patients from healthy controls, supporting more objective assessment.
  • Finding ties to an active public-private partnership with the U.S. Department of War, potentially strengthening government deployment and follow-on work.
  • Management flagged commercial potential in defense health programs, drug trials as an objective endpoint, and broader clinical psychiatry adoption.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Firefly Neuroscience Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606020740PRIMZONEFULLFEED9730430) on June 02, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.